Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19
NCT ID: NCT05063812
Last Updated: 2024-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
18 participants
OBSERVATIONAL
2020-09-21
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Investigators would like to complete a study of the program to understand:
1. Operational parameters of program performance, such as how many patients were enrolled and how many patients completed monitoring
2. Clinical course of patients, including their reported symptoms over time and clinical endpoints such as hospitalization or ICU admission
3. Patient satisfaction with program
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Monitoring of COVID-19 Positive Outpatients
NCT04853108
Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus)
NCT04337489
COVID-19 Watch + COVID-19 Pulse
NCT04581863
Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation
NCT04335097
Telemonitoraggio Domiciliare Della Saturazione Arteriosa di Ossigeno in Pazienti COVID-19
NCT05731583
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Investigators would like to perform analyses to test multiple hypotheses, including:
1. Patients discharged with a diagnosis of COVID-19 will be able to participate in a remote monitoring program.
2. A COVID-19 remote monitoring program will benefit patients.
3. Patients will be satisfied with their experience of a remote monitoring program and will have lower anxiety about their COVID-19 illness.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational
All these patients have been enrolled in the COVID-19 remote patient monitoring program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>=18
* Primary language English or Spanish
Exclusion Criteria
* Pregnant \> 16 weeks gestation
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
George Washington University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Neal Sikka
Professor of Emergency Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The George Washington University, Department of Emergency Medicine
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB#NCR202520
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.